The investment seeks long-term capital growth; income is a secondary consideration... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapValue
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CSHCX | 8.36 | 0.01 | +0.12% |
| NYLI Cushing® MLP Premier Class C | |||
| PMVAX | 20.07 | 0.01 | +0.05% |
| Putnam Sustainable Future A | |||
| VMGIX | 108.18 | N/A | N/A |
| Vanguard Mid-Cap Growth Index Investor | |||
| TNYRX | 10.74 | N/A | N/A |
| 1290 Loomis Sayles Multi-Asset Income R | |||
| RSECX | 17.60 | -0.13 | -0.73% |
| Russell Inv US Strategic Equity C | |||
A.I.dvisor indicates that over the last year, ACLAX has been closely correlated with VMVAX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACLAX jumps, then VMVAX could also see price increases.
| Ticker / NAME | Correlation To ACLAX | 1D Price Change % | ||
|---|---|---|---|---|
| ACLAX | 100% | N/A | ||
| VMVAX - ACLAX | 88% Closely correlated | N/A | ||
| MVCAX - ACLAX | 88% Closely correlated | +0.22% | ||
| JVMIX - ACLAX | 83% Closely correlated | N/A | ||
| JVMCX - ACLAX | 83% Closely correlated | N/A | ||
| VEVYX - ACLAX | 81% Closely correlated | N/A | ||
More | ||||